ARCHIVES

Zevalin Regimen Better Than Rituximab Alone For NHL

This article is from The Cancer Letter archive.

Vol. 24 No. 6 | June 29, 2001

Download PDF Visit The Full Archive

Related Articles

Early-Stage HER2+ Breast Cancer Patients Are At Significant Risk Of Recurrence

December 26, 2008

Upton Says NCI Must Take “Vigorous Role” In Prevention

February 3, 1978

ASCO Backs Central IRB For Cancer Trials, Stiffens Conflict-of-Interest Policies

May 2, 2003

NCI CTEP Approved Trials For the Month of January

January 31, 2014

AACR Polls Members On Tentative Date for Annual Meeting

April 11, 2003

In Brief: MB Ends Apportionment Carlo Croce To Head Fels Institute, Replacing Peter Magee Sept. 1

March 4, 1988